Literature DB >> 1493836

The relevance of residence time theory to pharmacokinetics.

M Weiss1.   

Abstract

Mesh：

Year:  1992        PMID： 1493836     DOI： 10.1007/bf02284953

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  55 in total

1.  Types of mean residence times.

Authors:  J G Wagner
Journal:  Biopharm Drug Dispos       Date:  1988 Jan-Feb       Impact factor: 1.627

2.  A general model of metabolite kinetics following intravenous and oral administration of the parent drug.

Authors:  M Weiss
Journal:  Biopharm Drug Dispos       Date:  1988 Mar-Apr       Impact factor: 1.627

3.  Mean time and first-pass metabolism.

Authors:  D Brockmeier; J Ostrowski
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  General treatment of mean residence time, clearance, and volume parameters in linear mammillary models with elimination from any compartment.

Authors:  E Nakashima; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1988-10

5.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

6.  Sampling strategies for noncompartmental estimation of mean residence time.

Authors:  D Z D'Argenio; D Katz
Journal:  J Pharmacokinet Biopharm       Date:  1983-08

7.  Model-independent assessment of accumulation kinetics based on moments of drug disposition curves.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Comments on mean residence time determination.

Authors:  E M Landaw; D Katz
Journal:  J Pharmacokinet Biopharm       Date:  1985-10

9.  Hemodynamic influences upon the variance of disposition residence time distribution of drugs.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

Review 10.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447
View more
  11 in total

1.  Residence time dispersion as a general measure of drug distribution kinetics: estimation and physiological interpretation.

Authors:  Michael Weiss
Journal:  Pharm Res       Date:  2007-05-18       Impact factor: 4.200

2.  Pharmacokinetics and toxicity of idarubicin in the rat.

Authors:  O Kuhlmann; S Hofmann; M Weiss
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Oct-Dec       Impact factor: 2.441

3.  Accuracy of noncompartmental pharmacokinetic parameters estimated from bolus injection and steady-state infusion data.

Authors:  M Looby; M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

4.  A novel extravascular input function for the assessment of drug absorption in bioavailability studies.

Authors:  M Weiss
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

5.  Empirical models for fitting of oral concentration time curves with and without an intravenous reference.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-01       Impact factor: 2.745

6.  Tissue distribution kinetics as determinant of transit time dispersion of drugs in organs: application of a stochastic model to the rat hindlimb.

Authors:  M Weiss; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1996-04

7.  The pharmacokinetics of tiopronin as such is unknown.

Authors:  M S Carlsson; T Denneberg; B M Emanuelsson; B Kågedal; S Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

8.  Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate.

Authors:  J Lötsch; U Muth-Selbach; I Tegeder; K Brune; G Geisslinger
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

9.  How does obesity affect residence time dispersion and the shape of drug disposition curves? Thiopental as an example.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-05-09       Impact factor: 2.745

10.  In silico labeling reveals the time-dependent label half-life and transit-time in dynamical systems.

Authors:  Thomas Maiwald; Julie Blumberg; Andreas Raue; Stefan Hengl; Marcel Schilling; Sherwin Kb Sy; Verena Becker; Ursula Klingmüller; Jens Timmer
Journal:  BMC Syst Biol       Date:  2012-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.